Your browser doesn't support javascript.
loading
Proper Use of Inflammatory Bowel Disease Drugs during Pregnancy.
Kanis, S L; van der Woude, C J.
Afiliação
  • Kanis SL; Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Dig Dis ; 34 Suppl 1: 61-6, 2016.
Article em En | MEDLINE | ID: mdl-27548630
ABSTRACT
Crohn's disease and ulcerative colitis, referred to as inflammatory bowel disease (IBD), are chronic, relapsing conditions. Patients are often diagnosed at a reproductive age, and therefore questions about fertility and reproductions often arise. Preconceptional counseling is the most important aspect in the management of IBD patients with a pregnancy wish. Patients should be counseled on the influence of IBD and IBD drugs on pregnancy. Most drugs are not related to adverse outcome while used during pregnancy. Active disease is related to adverse outcomes; therefore, it is of utmost importance to strive for remission before conception and during pregnancy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações na Gravidez / Fármacos Gastrointestinais / Colite Ulcerativa / Doença de Crohn Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações na Gravidez / Fármacos Gastrointestinais / Colite Ulcerativa / Doença de Crohn Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2016 Tipo de documento: Article